AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 42 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,192,215 | -20.9% | 1,561,696 | 0.0% | 1.24% | -17.6% |
| Q2 2023 | $26,783,086 | +84928.4% | 1,561,696 | 0.0% | 1.50% | -27.7% |
| Q1 2023 | $31,499 | -45.1% | 1,561,696 | -20.2% | 2.07% | -45.9% |
| Q4 2022 | $57,344 | -99.9% | 1,957,132 | -16.0% | 3.84% | +42.1% |
| Q3 2022 | $38,643,000 | +42.9% | 2,330,691 | +34.7% | 2.70% | +32.1% |
| Q2 2022 | $27,051,000 | -19.4% | 1,730,691 | -5.5% | 2.04% | -20.6% |
| Q1 2022 | $33,557,000 | +55.5% | 1,830,691 | 0.0% | 2.58% | +100.6% |
| Q4 2021 | $21,584,000 | -48.6% | 1,830,691 | -9.8% | 1.28% | -24.7% |
| Q3 2021 | $41,962,000 | -5.9% | 2,030,691 | 0.0% | 1.70% | +12.5% |
| Q2 2021 | $44,613,000 | – | 2,030,691 | – | 1.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $8,193,050 | 18.42% |
| TCG Crossover Management, LLC | 2,201,274 | $29,871,288 | 4.40% |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $27,672,609 | 4.29% |
| Sofinnova Investments, Inc. | 3,758,686 | $51,005,369 | 3.22% |
| GREAT POINT PARTNERS LLC | 1,091,233 | $14,808,032 | 2.70% |
| RA Capital Management | 8,263,982 | $112,142,236 | 2.21% |
| Cormorant Asset Management, LP | 1,561,696 | $21,192,215 | 1.24% |
| Frazier Life Sciences Management, L.P. | 1,204,867 | $16,350,045 | 1.09% |
| Octagon Capital Advisors LP | 497,370 | $6,749,311 | 1.04% |
| Ghost Tree Capital, LLC | 201,197 | $2,730,243 | 0.90% |